These cytokines are central mediators of metabolic inflammation, contributing to insulin resistance, adipocyte dysfunction, and hepatic steatosis through upregulating NF-κB and JNK signaling pathways [9,60]. The gene discussed is NFKB1; the disease is fatty liver disease.